{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T16:22:31Z","timestamp":1707322951349},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACYT)","award":["241312 (MOMH)","221262 (AQS)"],"award-info":[{"award-number":["241312 (MOMH)","221262 (AQS)"]}]},{"name":"UAA","award":["PIBB15-10N (MOMH)","PIFF14-1 (QSA)"],"award-info":[{"award-number":["PIBB15-10N (MOMH)","PIFF14-1 (QSA)"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.etp.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,5,7]],"date-time":"2017-05-07T03:15:28Z","timestamp":1494126928000},"page":"496-503","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Liver cirrhosis reversion is improved in hamsters with a neurointermediate pituitary lobectomy"],"prefix":"10.1016","volume":"69","author":[{"given":"A.","family":"Quintanar-Stephano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ventura-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"S\u00e1nchez-Alem\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.R.","family":"Aldaba-Muruato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cervantes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gonzalez-Blas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Mu\u00f1oz-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etp.2017.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2009.02.033","article-title":"Cirrhosis regression in chronic hepatitis C: an old tale with a new ending","volume":"136","author":"Aghemo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.etp.2017.04.006_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000339078","article-title":"Allopurinol reverses liver damage induced by chronic carbon tetrachloride treatment by decreasing oxidative stress, TGF-\u03b2 production and NF-\u03baB nuclear translocation","volume":"92","author":"Aldaba-Muruato","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.etp.2017.04.006_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/frne.1993.1004","article-title":"Vasopressinergic control of pituitary adrenocorticotrophin secretion comes of age","volume":"14","author":"Antoni","year":"1993","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.etp.2017.04.006_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1254\/jphs.08R17FM","article-title":"New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia","volume":"109","author":"Arai","year":"2009","journal-title":"Pharmacol. Sci."},{"key":"10.1016\/j.etp.2017.04.006_bib0025","series-title":"Hypothalamic Regulation of Hormonal Functions, in Ganong\u2019s Review of Medical Physiology","first-page":"232","author":"Barret","year":"2010"},{"key":"10.1016\/j.etp.2017.04.006_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.etp.2017.04.006_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/gast.1997.v113.pm9247484","article-title":"Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells","volume":"113","author":"Bataller","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.etp.2017.04.006_bib0040","series-title":"Cytokines, Stress and Immunity","first-page":"215","article-title":"Immunoconversion in the acute phase response","author":"Berczi","year":"2007"},{"key":"10.1016\/j.etp.2017.04.006_bib0045","series-title":"Stress, Hormones and the Immune System","first-page":"9","article-title":"The neuroendocrine system: anatomy, physiology and responses to stress","author":"Buckingham","year":"1997"},{"key":"10.1016\/j.etp.2017.04.006_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1749-6632.2000.tb05448.x","article-title":"Perturbations of arginine vasopressin secretion during inflammatory stress: pathophysiologic implications","volume":"917","author":"Chikanza","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.etp.2017.04.006_bib0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cbdd.12229","article-title":"Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies","volume":"83","author":"Contreras-Romo","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.etp.2017.04.006_bib0060","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/en.2002-220363","article-title":"[1-deamino-4-cyclohexylalanine] Arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors","volume":"143","author":"Derick","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.etp.2017.04.006_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20030062","article-title":"Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis","volume":"105","author":"Ferguson","year":"2003","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.etp.2017.04.006_bib0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/lt.21784","article-title":"The natural history of hepatitis C cirrhosis after liver transplantation","volume":"15","author":"Firpi","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1016\/j.etp.2017.04.006_bib0075","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.etp.2017.04.006_bib0080","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.etp.2017.04.006_bib0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0025-7753(04)74271-2","article-title":"Cytokines and liver cirrhosis","volume":"122","author":"Genesc\u00e0","year":"2004","journal-title":"Med. Clin."},{"key":"10.1016\/j.etp.2017.04.006_bib0090","first-page":"4","article-title":"Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation","volume":"12","author":"Goncharova","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.etp.2017.04.006_bib0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1997.tb48393.x","article-title":"The hypothalamic-pituitary-adrenal axis in autoimmunity","volume":"823","author":"Harbuz","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.etp.2017.04.006_bib0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1351.005","article-title":"Stress in autoimmune disease models","volume":"1069","author":"Harbuz","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.etp.2017.04.006_bib0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cld.2008.07.002","article-title":"Immune interactions in hepatic fibrosis","volume":"12","author":"Holt","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.etp.2017.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-4871-3_1","article-title":"Vasopressin receptors. A historical survey","volume":"449","author":"Jard","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.etp.2017.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: from molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.etp.2017.04.006_bib0120","series-title":"Perspectives on Vasopressin","first-page":"176","article-title":"Vasopressin and the cardiovascular system","author":"Laycock","year":"2010"},{"key":"10.1016\/j.etp.2017.04.006_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4137\/BMI.S10009","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"Liu","year":"2012","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.etp.2017.04.006_bib0130","series-title":"Manual of Histologic Staining Methods","first-page":"121","author":"Luna","year":"1968"},{"key":"10.1016\/j.etp.2017.04.006_bib0135","first-page":"609","article-title":"vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.etp.2017.04.006_bib0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration","volume":"213","author":"Michalopulus","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.etp.2017.04.006_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5009\/gnl14459","article-title":"Doxazosin treatment attenuates carbon tetrachloride-induced liver fibrosis in hamsters through a decrease in transforming growth factor \u03b2 secretion","volume":"10","author":"Mu\u00f1oz-Ortega","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.etp.2017.04.006_bib0150","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/FJC.0000000000000151","article-title":"Effects of angiotensin-(1-7) on the proliferation and collagen synthesis of arginine vasopressin-stimulated rat cardiac fibroblasts: role of mas receptor-calcineurin-NF-\u03baB signaling pathway","volume":"64","author":"Niu","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.etp.2017.04.006_bib0155","first-page":"2016","article-title":"Effects of the neurointermediate pituitary lobectomy (LNI) oN pituitary hormones blood level in the rat","author":"Organista-Esparza","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.etp.2017.04.006_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000078441","article-title":"Effects of neurointermediate pituitary lobectomy on humoral and cell-mediated immune responses in the rat","volume":"11","author":"Quintanar-Stephano","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.etp.2017.04.006_bib0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13105-010-0004-z","article-title":"Hypophysectomy and neurointermediate pituitary lobectomy decrease humoral immune responses to T-independent and T-dependent antigens","volume":"66","author":"Quintanar-Stephano","year":"2010","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.etp.2017.04.006_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000330578","article-title":"Effects of neurointermediate pituitary lobectomy and desmopressin on acute experimental autoimmune encephalomyelitis in Lewis rats","volume":"19","author":"Quintanar-Stephano","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.etp.2017.04.006_bib0175","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2362.1997.2070754.x","article-title":"Formation of black pigment gallstone in a hamster model of experimental cirrhosis","volume":"27","author":"Sakata","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.etp.2017.04.006_bib0180","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.etp.2017.04.006_bib0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1440-1681.2007.04852.x","article-title":"Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells","volume":"35","author":"Tahara","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.etp.2017.04.006_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2012.00071","article-title":"Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis","volume":"3","author":"Ueha","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.etp.2017.04.006_bib0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.etp.2017.04.006_bib0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FJC.0b013e3181d706ae","article-title":"Effects of arginine vasopressin on differentiation of cardiac fibroblasts into myofibroblasts","volume":"55","author":"Yan-Hong","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299316302329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299316302329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T02:36:19Z","timestamp":1602038179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299316302329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0940299316302329"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2017.04.006","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver cirrhosis reversion is improved in hamsters with a neurointermediate pituitary lobectomy","name":"articletitle","label":"Article Title"},{"value":"Experimental and Toxicologic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etp.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}